Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease

NCT00054613 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft-versus-Host Disease

Interventions

DRUG: Methoxsalen
PROCEDURE: Extracorporeal Photopheresis

Sponsor

Mallinckrodt